W1 (Pyridostigmine Bromide Extended-Release 180 mg)
Pill with imprint W1 is Yellow, Capsule-shape and has been identified as Pyridostigmine Bromide Extended-Release 180 mg. It is supplied by Amneal Pharmaceuticals LLC.
Pyridostigmine is used in the treatment of myasthenia gravis; reversal of nondepolarizing muscle relaxants; nerve agent pretreatment and belongs to the drug class cholinergic muscle stimulants. Risk cannot be ruled out during pregnancy. Pyridostigmine 180 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for W1
Pyridostigmine Bromide Extended-Release
- Imprint
- W1
- Strength
- 180 mg
- Color
- Yellow
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Cholinergic muscle stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amneal Pharmaceuticals LLC
- National Drug Code (NDC)
- 00115-1404
- Inactive Ingredients
-
carnauba wax,
copovidone,
magnesium stearate,
silicon dioxide
Note: Inactive ingredients may vary.
Related images for "W1"
More about pyridostigmine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (43)
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: cholinergic muscle stimulants
Patient resources
- Drug Information
- Pyridostigmine Extended-Release Tablets
- Pyridostigmine Injection
- Pyridostigmine Liquid
- Pyridostigmine Tablets
Other brands
Mestinon, Mestinon Timespan, Regonol
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.